Medicare Enrolled
Dr. Rugen Alda, MD
Family Medicine · Clyde, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alda
Dr. Rugen Alda is a family medicine specialist in Clyde, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alda performed 2,204 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alda received a total of $14,405 from 55 pharmaceutical and/or device companies across 942 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in OH
$14,405 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,204
Medicare services
Top 5% in OH for family medicine
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
899 | $61 | $175 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
397 | $57 | $176 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
172 | $70 | $240 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
159 | $139 | $305 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
93 | $125 | $235 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
92 | $77 | $155 |
| Annual depression screening | 86 | $18 | $30 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
51 | $9 | $30 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
50 | $87 | $250 |
| Annual alcohol misuse screening, 5 to 15 minutes | 43 | $18 | $44 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
35 | $129 | $370 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $54 | $160 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
25 | $43 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $29 | $46 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
15 | $72 | $180 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
14 | $83 | $241 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
12 | $66 | $185 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
11 | $3 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,405
Total received (2018-2024)
Avg $2,058/year across 7 years
Top 3% in OH for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
942
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,751
2023
$1,245
2022
$2,166
2021
$2,507
2020
$1,729
2019
$2,069
2018
$2,938
Payments by company (2024)
Novo Nordisk Inc
$283
AstraZeneca Pharmaceuticals LP
$188
ABBVIE INC.
$172
Bayer Healthcare Pharmaceuticals Inc.
$156
PFIZER INC.
$155
Lilly USA, LLC
$143
Avadel CNS Pharmaceuticals, LLC
$117
Otsuka America Pharmaceutical, Inc.
$105
Abbott Laboratories
$97
GlaxoSmithKline, LLC.
$65
Amgen Inc.
$44
Novartis Pharmaceuticals Corporation
$35
Phathom Pharmaceuticals, Inc.
$30
Dexcom, Inc.
$28
Antares Pharma, Inc.
$20
Seqirus USA Inc
$18
Teva Pharmaceuticals USA, Inc.
$18
UCB, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Janssen Pharmaceuticals, Inc
$15
Alkermes, Inc.
$15
ACADIA Pharmaceuticals Inc
$14
Top 3 companies account for 36.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,029
AstraZeneca Pharmaceuticals LP
$1,243
Amgen Inc.
$1,055
SANOFI-AVENTIS U.S. LLC
$794
AbbVie Inc.
$788
PFIZER INC.
$700
Lilly USA, LLC
$640
Novartis Pharmaceuticals Corporation
$617
Janssen Pharmaceuticals, Inc
$596
Biohaven Pharmaceuticals, Inc.
$581
GlaxoSmithKline, LLC.
$556
ABBVIE INC.
$535
Boehringer Ingelheim Pharmaceuticals, Inc.
$466
Takeda Pharmaceuticals U.S.A., Inc.
$342
Biohaven Pharmaceutical Holding Company Ltd.
$332
Ironwood Pharmaceuticals, Inc
$296
Otsuka America Pharmaceutical, Inc.
$284
Astellas Pharma US Inc
$234
Bayer Healthcare Pharmaceuticals Inc.
$232
Teva Pharmaceuticals USA, Inc.
$210
Merck Sharp & Dohme Corporation
$187
Allergan Inc.
$156
Amarin Pharma Inc.
$154
E.R. Squibb & Sons, L.L.C.
$126
Avadel CNS Pharmaceuticals, LLC
$117
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$107
Abbott Laboratories
$97
Merck Sharp & Dohme LLC
$87
Avanir Pharmaceuticals, Inc.
$79
Bayer HealthCare Pharmaceuticals Inc.
$78
Corcept Therapeutics
$66
Dexcom, Inc.
$62
Alkermes, Inc.
$48
NESTLE HEALTHCARE NUTRITION INC.
$46
Allergan, Inc.
$45
Scilex Pharmaceuticals Inc.
$44
Daiichi Sankyo Inc.
$32
Phathom Pharmaceuticals, Inc.
$30
Shire North American Group Inc
$28
Kyowa Kirin, Inc.
$28
Xeris Pharmaceuticals, Inc.
$28
ACADIA Pharmaceuticals Inc
$27
Horizon Therapeutics plc
$27
Antares Pharma, Inc.
$20
Seqirus USA Inc
$18
UCB, Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
Horizon Pharma plc
$16
Smith & Nephew, Inc.
$13
Clarus Therapeutics Inc.
$13
Neurocrine Biosciences, Inc.
$13
Alfasigma USA, Inc.
$13
Lundbeck LLC
$13
Kowa Pharmaceuticals America, Inc.
$12
Regeneron Healthcare Solutions, Inc.
$11
Top 3 companies account for 30.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIMOVIG · AIRSUPRA · AJOVY · ANORO ELLIPTA · AREXVY · AUSTEDO · Aimovig · Austedo XR · BAQSIMI · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Briviact · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cryvista · DUZALLO · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FASENRA · FLULAVAL · FREESTYLE INSULINX · FREESTYLE LIBRE 3 · Flucelvax · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · INGREZZA · INJECTAFER · INVEGA SUSTENNA · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LUMRYZ · LYBALVI · LYRICA · MOUNJARO · MYDAYIS · MYRBETRIQ · Myrbetriq · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Otezla · Ozempic · PENNSAID · PRALUENT · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · Santyl · Saxenda · Seglentis · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · VIBERZI · VIIBRYD · VOQUEZNA · VOWST · VPRIV · VRAYLAR · VYVANSE · Vascepa · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
125
County median income
$62,500
Nearest hospital to ZIP centroid (approximate)
BELLEVUE HOSPITAL
7.3 mi
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alda is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alda experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Alda performed 899 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alda receive payments from pharmaceutical companies?
Yes. Dr. Alda received a total of $14,405 from 55 companies across 942 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alda's costs compare to other family medicine physicians in Clyde?
Dr. Alda's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Clyde
Browse family medicine physicians in Clyde ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in OH
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in OH
Which OH family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology